Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Shiloh

Showing results (11-20 of 125) with videos related to

Pageof 13
Sort By:
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|November 18, 1997
Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress?G Rotman, Y Shiloh
In Vitro|June 1, 1978
An improved technique of preparing bone-marrow specimens for cytogenetic analysisY Shiloh, M M Cohen
Annual Review of Immunology|January 1, 1997
The genetic defect in ataxia-telangiectasiaM F Lavin, Y Shiloh
Current Opinion in Immunology|August 1, 1996
Ataxia-telangiectasia: a multifaceted genetic disorder associated with defective signal transductionM F Lavin, Y Shiloh
Advances in Cancer Research|October 23, 2001
ATM: genome stability, neuronal development, and cancer cross pathsY Shiloh, M B Kastan
Mutation Research|January 1, 1977
Genetic toxicology of lysergic acid diethylamide (LSD-25)M M Cohen, Y Shiloh
Mutation Research|April 1, 1985
Cells from patients with ataxia telangiectasia are abnormally sensitive to the cytotoxic effect of a tumor promoter, phorbol-12-myristate-13-acetateY Shiloh, E Tabor, Y Becker
Kroc Foundation Series|January 1, 1985
In vitro phenotype of ataxia-telangiectasia (AT) fibroblast strains: clues to the nature of the "AT DNA lesion" and the molecular defect in ATY Shiloh, E Tabor, Y Becker
Carcinogenesis|October 1, 1983
Abnormal response of ataxia-telangiectasia cells to agents that break the deoxyribose moiety of DNA via a targeted free radical mechanismY Shiloh, E Tabor, Y Becker
Mutation Research|February 1, 1983
Similar repair of O6-methylguanine in normal and ataxia-telangiectasia fibroblast strains. Deficient repair capacity of lymphoblastoid cell lines does not reflect a genetic polymorphismY Shiloh, E Tabor, Y Becker
Pageof 13

Showing results (11-20 of 125) with videos related to

Sort By:
Pageof 13
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|November 18, 1997
Ataxia-telangiectasia: is ATM a sensor of oxidative damage and stress?G Rotman, Y Shiloh
In Vitro|June 1, 1978
An improved technique of preparing bone-marrow specimens for cytogenetic analysisY Shiloh, M M Cohen
Annual Review of Immunology|January 1, 1997
The genetic defect in ataxia-telangiectasiaM F Lavin, Y Shiloh
Current Opinion in Immunology|August 1, 1996
Ataxia-telangiectasia: a multifaceted genetic disorder associated with defective signal transductionM F Lavin, Y Shiloh
Advances in Cancer Research|October 23, 2001
ATM: genome stability, neuronal development, and cancer cross pathsY Shiloh, M B Kastan
Mutation Research|January 1, 1977
Genetic toxicology of lysergic acid diethylamide (LSD-25)M M Cohen, Y Shiloh
Mutation Research|April 1, 1985
Cells from patients with ataxia telangiectasia are abnormally sensitive to the cytotoxic effect of a tumor promoter, phorbol-12-myristate-13-acetateY Shiloh, E Tabor, Y Becker
Kroc Foundation Series|January 1, 1985
In vitro phenotype of ataxia-telangiectasia (AT) fibroblast strains: clues to the nature of the "AT DNA lesion" and the molecular defect in ATY Shiloh, E Tabor, Y Becker
Carcinogenesis|October 1, 1983
Abnormal response of ataxia-telangiectasia cells to agents that break the deoxyribose moiety of DNA via a targeted free radical mechanismY Shiloh, E Tabor, Y Becker
Mutation Research|February 1, 1983
Similar repair of O6-methylguanine in normal and ataxia-telangiectasia fibroblast strains. Deficient repair capacity of lymphoblastoid cell lines does not reflect a genetic polymorphismY Shiloh, E Tabor, Y Becker
Pageof 13